Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease: Pre-Treatment Prediction of Immunogenicity and Response. A Prospective Observational Study.

NCT07644117 is registered in ClinicalTrials.gov with Shmuel Kivity, MD as lead sponsor.

NCT NCT07644117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07644117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease: Pre-Treatment Prediction of Immunogenicity and Response. A Prospective Observational Study.
Lead sponsor
Shmuel Kivity, MD
Phase
Observational
Overall status
Recruiting
Start date
January 4, 2025
Completion date
December 31, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), ibd (inflammatory bowel disease), ulcerative colitis (uc)